Immatics N.V. (IMTX)
NASDAQ·Healthcare·Biotechnology
$9.26
+2.66%
Mkt Cap $1.23B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+170.0%
Consensus $25.00 vs current $9.26
NASDAQ·Healthcare·Biotechnology
$9.26
+2.66%
Mkt Cap $1.23B
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$25.00
Range $25.00 – $25.00
+170.0%
Consensus $25.00 vs current $9.26